RICK HARRISON — STAR OF THE HIT TV SHOW ‘PAWN STARS’
SHARES HIS WAKE-UP CALL WITH YOUR VIEWERS
THE FORGOTTEN FAT: MOST CONSUMERS ARE UNAWARE OF HEALTH RISKS FROM VERY HIGH TRIGLYCERIDES1
1 out of 3 Americans have elevated triglyceride levels.
Cholesterol levels and their importance are often in the news, but very high triglycerides are also an important health risk that Americans should be aware of. Triglycerides are often called “the forgotten fat” because they tend to be overlooked by patients and doctors who only focus on lowering their cholesterol.
Rick Harrison, star of the hit show “Pawn Stars,” was recently diagnosed with very high triglycerides. After his diagnosis he learned about an effective way to manage it. Rick will be answering questions about his journey of discovery concerning his very high triglycerides.
Rick will also answer questions about his new game show “Pawnography,” including fun facts about the pawn shop business.
Joining Rick is Dr. David Sabgir, a board-certified cardiologist and renowned health and wellness expert. He will be able to speak about why prescribing an EPA-only omega-3 is so important to lowering very high triglyceride levels.
About Rick Harrison: He is a charismatic personality and star of the hit show “Pawn Stars”. He’s currently in production on his new game show “Pawnography” which will premiere this summer. Rick will be a dynamic, fun guest who wants to share his journey of discovery with your viewers.
About Dr. David Sabgir: Dr. Sabgir isa board-certified cardiologist and a renowned health and wellness expert who created Walk with a Doc (WWAD) – a program dedicated to improving health and wellness – in 2005. In addition to practicing cardiology full-time, he passionately serves as WWAD’s President and CEO. Dr. Sabgir can speak to the importance of working with a doctor to find a personalized treatment plan that is tailored to the individual.
[1]Fairleigh Dickinson University Public Mind Omega-3 Consumer Study. April 2013
Interview Provided By Amarin, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.
